Decreased miR-16-5p and increased NOTCH2 expression levels were identified in SSc serum samples, suggesting that miR-16-5p interferes in SSc pathogenesis by modulating fibroblast to myofibroblast differentiation [84]. The gene discussed is NOTCH2; the disease is systemic sclerosis.